Document Detail

Forearm compartment syndrome following thrombolytic therapy for acute myocardial infarction.
MedLine Citation:
PMID:  8070154     Owner:  NLM     Status:  MEDLINE    
Thrombolytic therapy for myocardial infarction may contribute to bleeding complications when central venous or arterial access is required, but peripheral venous access is usually uncomplicated. We report a patient in whom tissue plasminogen activator and subsequent intravenous heparin exacerbated bleeding from a disrupted intravenous access site, leading to acute compartment syndrome requiring surgical decompression. This case emphasizes the risks associated with iatrogenic trauma during thrombolytic therapy.
J Burnside; J M Costello; N J Angelastro; J Blankenship
Related Documents :
12470374 - Ultrasound enhancement of thrombolytic therapy: observations and mechanisms.
1828324 - Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial ...
11436524 - Thrombolytic therapy during cardiopulmonary resuscitation and the role of coagulation a...
3392324 - Early recovery of left ventricular function after thrombolytic therapy for acute myocar...
24827794 - Fragmented ecg as a risk marker in cardiovascular diseases.
5928534 - Ventricular aneurysm following myocardial infarction.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Clinical cardiology     Volume:  17     ISSN:  0160-9289     ISO Abbreviation:  Clin Cardiol     Publication Date:  1994 Jun 
Date Detail:
Created Date:  1994-09-23     Completed Date:  1994-09-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7903272     Medline TA:  Clin Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  345-7     Citation Subset:  IM    
Department of Cardiology, Geisinger Medical Center, Danville, Pennsylvania 17822.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Compartment Syndromes / etiology*
Middle Aged
Myocardial Infarction / drug therapy
Thrombolytic Therapy / adverse effects*
Tissue Plasminogen Activator / adverse effects
Reg. No./Substance:
EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Radiofrequency catheter ablation of both atrial ventricular nodal reentrant and atrial ventricular r...
Next Document:  The Chronic Arthritis Systemic Index (CASI).